noom microdose glp-1 What if you could start smaller…and still move forward? Microdosing can offer a more personalized approach to GLP-1s, using less, but with intention. Small shifts. Real impact. Tap through to learn more Noom Unveils Microdose GLP-1 Program
Description
Carranza-Naval MJ, Del Marco A, Hierro-Bujalance C, Alves-Martinez P, Infante-Garcia C, Vargas-Soria M, et al
In general, the majority of studies suggest that the risk of side effects with DPP-4 inhibitors is equivalent to that of a placebo (inactive pill) [14]
Phase 3 clinical trials, which test new treatments in larger groups of people, are particularly crucial in ensuring that a drug works as intended and has minimal side effects
PlexusDx's Precision Peptide Genetic Test examines 14 metabolic pathways and 150+ genetic insights, including variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313)all of which influence how your body responds to semaglutide or tirzepatide
Neurology 104 (6), e213447
These are subject to provider approval and availability
